Facebook "improperly" blocked some political ads due to "technical issues" when implementing its ban on new ads in the week before Election Day, the company said in a blog post Thursday.
Facebook said this was an automated process and that "no ad was paused or rejected by a person, or because of any partisan consideration." OpEd: Traitor Mark Zuckerberg using the using the dog ate my homewoirk defense.
Biden's campaign had earlier on Thursday slammed Facebook after thousands of its ads were blocked, saying it had "no sense of the scale of the problem, who it is affecting, and their plan to resolve it."
"It is abundantly clear that Facebook was wholly unprepared to handle this election despite having four years to prepare," the campaign told Business Insider in a statement. OpEd: That's a nice way of saying criminal Mark Zuckerberg is working for Trump.
Facebook admitted on Thursday that it "improperly" restricted or paused some political and social issue ads due to technical glitches with its ad review systems.
In a blog post Thursday evening, Facebook said that "technical flaws... caused a number of ads from a wide range of advertisers to be paused improperly, and prevented advertisers from making permissible changes to their ads."
"While this impacted a small proportion of the ads about politics and social issues in our system, we regret any disruption in the delivery of these ads during this period," the company said. "We have implemented changes to fix these issues, and most political ads are now running without any problems."
Facebook announced in early September that it wouldn't accept new ads in the week before the election, and said Thursday that the restriction kicked in Tuesday at 12:01 a.m. PT. But due to a combination of technical issues with its automated systems that review ads as well as a lack of clarity in communicating nuances of the election week policy to advertisers, some ads were paused or restricted incorrectly, the company said.
No comments:
Post a Comment
If you support Trump you deserve cancer.